AVERY JOHNSON: Open Payments
NPI 1972116978 · NORWALK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 56 payments from 14 companies in 2025. Trend: 2023 $217 · 2024 $1,142 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $234 |
| Abbott Laboratories | 4 | $214 |
| PFIZER INC. | 8 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $132 |
| Amgen Inc. | 3 | $112 |
| Merck Sharp & Dohme LLC | 5 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $99 |
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| Alnylam Pharmaceuticals Inc. | 4 | $80 |
| Esperion Therapeutics, Inc. | 2 | $54 |
Products named: CARDIOMEMS, LEQVIO, JARDIANCE, VYNDAQEL, VERQUVO, Kerendia, ENTRESTO, ONPATTRO.
Industry payments across CT — which companies pay providers there.
